HankenKElingPHildebrandtH. Is there a cognitive signature for MS-related fatigue?Mult Scler2015; 21: 353–354.
2.
FeinsteinA. Is there a cognitive signature for multiple sclerosis-related fatigue?Mult Scler2015; 21: 353–354.
3.
HildebrandtHElingP. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis. J Clin Exp Neuropsychol2014; 36: 410–417.
4.
RabinowitzARFisherAJArnettPA. Neurovegetative symptoms in patients with multiple sclerosis: Fatigue, not depression. Journal of the International Neuropsychological Society2010; 17: 1–10.
5.
ChristensenJRBörnsenLRatzerR. Systemic inflammation in progressive multiple sclerosis involves follicular t-helper, th17- and activated B-cells and correlates with progression. PLOS ONE2013; 8: e57820.
6.
InogesSMerinoJBandresE. Cytokine flow cytometry differentiates the clinical status of multiple sclerosis (MS) patients. Clin Exp Immunol1999; 115: 521–525.
7.
KarniAAbrahamMMonsonegoA. Innate immunity in multiple sclerosis: Myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J Immunol2006; 117: 4196–4202.
8.
FrischerJMBramowSDal-BiancoA. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain2009; 132: 1175–1189.
9.
MagliozziRHowellOVoraA. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain2007; 130: 1089–1104.
10.
MorrisGBerkMWalderK. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med2015; 6: 28.
